Bluebook
Diagnostics & Tools May 2021
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
- CellCarta has acquired Reveal Biosciences
- NeoGenomics Laboratories has agreed to acquire Inivata for $390mm
- Caris Life Sciences has received $830mm in a round of funding led by Sixth Street Partners